Other
Enterocolitis
5
Pipeline Programs↗
0
Active Trials↗
3
Companies Involved↗
Enterocolitis is an early-stage landscape with 5 programs across 3 companies. The most active players are CD Pharma India Pvt. Ltd., Eastern Cooperative Oncology Group, Hikma Pharmaceuticals LLC. 3 therapies are approved.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical
No programs
Phase 1
No programs
Phase 3
No programs
Analysis
Trial Status
4
clinical trials
Unknown status2 · 50%
Completed2 · 50%
Clinical Trials
Trial Activity
The Role of Short-course Ceftriaxone Therapy in the Treatment of Severe Nontyphoidal Salmonella Enterocolitis
Unknown status·—·Phase 4·NCT01278017·200 enrolled
Effect of Probiotics (Bio-Three) in Children's Enterocolitis
Completed·—·Phase 4·NCT00463190·300 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)